Diametric Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,013
Closed -$897K 397
2024
Q3
$897K Sell
1,013
-652
-39% -$586K 0.44% 56
2024
Q2
$1.51M Buy
1,665
+470
+39% +$376K 0.82% 22
2024
Q1
$930K Buy
1,195
+362
+43% +$258K 0.52% 49
2023
Q4
$486K Sell
833
-494
-37% -$288K 0.3% 106
2023
Q3
$713K Buy
1,327
+139
+12% +$71.6K 0.3% 103
2023
Q2
$557K Buy
+1,188
New +$498K 0.25% 112
2022
Q4
Sell
-3,213
Closed -$1.04M 345
2022
Q3
$1.04M Buy
+3,213
New +$1.02M 0.52% 60
2020
Q1
Sell
-18,813
Closed -$2.47M 144
2019
Q4
$2.47M Buy
+18,813
New +$2.18M 1.81% 14
2018
Q1
Sell
-9,389
Closed -$793K 106
2017
Q4
$793K Buy
+9,389
New +$799K 0.48% 75

Other funds holding LLY

Diametric Capital's LLY Position: Q4 2024 in Review

Diametric Capital sold out of Eli Lilly (LLY) in Q4 2024, closing a stake of 1,013 shares — an estimated $897K sold.

Diametric Capital first reported a position in LLY in Q4 2017 and held it in 9 quarters. The position peaked at $2.47M in Q4 2019. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Diametric Capital reported no remaining Eli Lilly position as of Q4 2024 after selling out during the quarter.
  • Diametric Capital sold 1,013 Eli Lilly shares in Q4 2024, an estimated $897K.
  • Diametric Capital first reported a position in Eli Lilly in Q4 2017 and held it in 9 quarters.
  • Diametric Capital's Eli Lilly position peaked at $2.47M in Q4 2019.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Diametric Capital's 13F filing for Q4 2024, filed 12 Feb 2025.